Changzhou Qianhong Biopharma CO.,LTD (SHE:002550)

China flag China · Delayed Price · Currency is CNY
7.62
+0.08 (1.06%)
Mar 10, 2026, 2:05 PM CST
36.56%
Market Cap 9.42B
Revenue (ttm) 1.53B
Net Income (ttm) 429.67M
Shares Out 1.25B
EPS (ttm) 0.34
PE Ratio 22.27
Forward PE 20.94
Dividend 0.12 (1.57%)
Ex-Dividend Date May 29, 2025
Volume 8,683,423
Average Volume 12,704,077
Open 7.32
Previous Close 7.54
Day's Range 7.32 - 7.65
52-Week Range 5.38 - 12.75
Beta 0.20
RSI 40.27
Earnings Date Apr 24, 2026

About SHE:002550

Changzhou Qianhong Biopharma CO.,LTD manufactures and distributes polysaccharide and protease drugs in China. The company offers heparin sodium, heparin calcium, enoxaparin sodium, dalteparin sodium, nadroparin calcium, pancreatin, heparinoid API, kallidinogenase, and asparaginase. It also provides low molecular weight heparin, compound digestive enzyme preparations, and health products. In addition, the company exports its products. The company was founded in 1971 and is headquartered in Changzhou, China. [Read more]

Sector Healthcare
Founded 1971
Employees 979
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002550
Full Company Profile

Financial Performance

In 2024, SHE:002550's revenue was 1.53 billion, a decrease of -15.88% compared to the previous year's 1.81 billion. Earnings were 356.03 million, an increase of 95.77%.

Financial Statements

News

There is no news available yet.